75
Tests and monitoring in HIV infection UK standard of care and some other useful tests Matthew Williams UK CAB

Tests and monitoring in HIV infection

  • Upload
    jaser

  • View
    43

  • Download
    0

Embed Size (px)

DESCRIPTION

UK standard of care and some other useful tests Matthew Williams UK CAB. Tests and monitoring in HIV infection. UK standard of care and some other useful tests. Tests and monitoring in HIV infection. CD4 count Viral load Resistance Therapeutic drug monitoring. - PowerPoint PPT Presentation

Citation preview

Page 1: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care and some other useful tests

Matthew WilliamsUK CAB

Page 2: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care and some other useful tests

Page 3: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 countViral load

ResistanceTherapeutic drug monitoring

Page 4: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

●Blood test●Used to judge how far HIV disease has advanced●Helps predict the risk of opportunistic infections●Most useful when it is compared with the count obtained from an earlier test.

Page 5: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

CD4 dips on HIV infection from a normal count of 500-1,500 cells in a cubic millimeter (mm3) of blood (a drop, more or less), recovers somewhat, then falls over time down to as low as 0.

Page 6: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

CD4 <200 = greater risk of opportunistic infections (OIs) = “AIDS” = threshold for prophylaxis eg for PCP = bottom of UK threshold for starting combination therapy

CD4 <50 = very great risk of OIs

Page 7: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

CD4 over 350: treatment not recommended

CD4 any count: treatment recommended if “symptomatic”

BHIVA, Treatment of HIV-infected adults with antiretroviral therapy (2006)

Page 8: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

CD4 count lower in pregnancy – temporary drop of 50 cells/mm3

Page 9: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

CD4 count

CD4% - CD4 cells as proportion of all lymphocytes (white blood cells), normally about 40% in adults

CD4% is used to monitor babies and children who have higher CD4 counts

Page 10: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Viral load

●Blood test (can be other serum eg CSF)●Used to judge whether treatment is working (early infection?)●Helps predict the risk of disease progression?●Most useful when it is compared with the count obtained from an earlier test.

Page 11: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Viral load

After infection, viral load surges to a very high for the first weeks or months

Often 1,000,000+ copies in a millilitre (mL) of blood, when you are very infectious

Viral load falls as the body controls HIV infection then rises over time as immunity is damaged

Page 12: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Viral load

When you are on HIV treatment, your viral load should be reduced to “undetectable” = <50 copies/mL = 1.7 log10

Page 13: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Viral load

Blip = 1 viral load test detectable (over 50 copies) – 2 of these may be a trend and indicate “virological failure”

Page 14: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Viral load

Viral load is usually a PCR (polymerase chain reaction) quantitative (counting) test for HIV RNA - research tests can measure viral load below 50 copies

Other tests: bDNA (branched DNA), NASBA (nucleic acid sequence based amplification)

Page 15: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Resistance test

●Blood test (can be other serum eg CSF)●Used to judge whether treatment will work●Involves interpretation●Two types: genotype and phenotype●Viral load needs to be over 500 copies/mL for the test to work

Page 16: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Resistance test

Resistance test

Page 17: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Resistance test

Genotype looks at genetic make up of HIV viruses in infection and compares this to what is known about which mutations lead to resistance

Phenotype looks at whether the drugs work in a test tube

Page 18: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Resistance test

Minority species of resistant virus may be missed by conventional resistance testing (ie if less than 10% of your virus is resistant the test may not pick this up).

In patients without evidence of transmitted resistance, a suboptimal virological response to first-line therapy (<1 log10 copies/mL drop in viral load by 4–8 weeks) should prompt resistance testing at that time.BHIVA, Treatment of HIV-infected adults with antiretroviral therapy (2006)

Page 19: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Resistance test

Page 20: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Therapeutic drug monitoring (TDM)

Measures drug levels in the blood - requires blood samples at recorded time intervals after a drug dose

Practical uses for NNRTIs and PIs

Page 21: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Therapeutic drug monitoring (TDM)

Freely available at low (£45/drug) or no cost (if covered by drug company) from University of Liverpool Department of Pharmacology.

http://www.hiv-druginteractions.org/

http://www.delphicdiagnostics.com/

Page 22: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Therapeutic drug monitoring (TDM)

Drug levels vary – much evidence of this – recommended dose is based on averages

University of Liverpool TDM audit – 20-25% of children on NNRTIs or PIs using drugs below therapeutic level.

http://www.i-base.info/htb/v7/htb7-6/University.html

Page 23: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care (BHIVA)

All patients should have:i) a resistance test at diagnosis, ii) before starting HAART, iii) if viral load does not drop by <1log10 after 4-

8 weeks after starting HAART, (genotype) iv) after virological failure

Page 24: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care

BHIVA – viral load before and 4-8 weeks after starting treatment (as necessary

thereafter)

Page 25: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care

BHIVA – CD4 count before treatment (as necessary thereafter)

Page 26: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care

BHIVA – TDM for management of drug interactions, pregnancy and paediatrics,

highly treatment-experienced patients when TDM and resistance test results can be integrated, kidney or liver impairment,

transplant patients, drug toxicity, alternative dosing where safety and efficacy has not

been established

Page 27: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

UK standard of care and some other useful tests

Page 28: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection● Liver enzymes● Kidney function● Urine● Albumin● Bone density● Glucose● Platelets● Red blood count● White blood count● Lipids

Page 29: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection● C-reactive protein● DEXA scan● Chest x-ray● Sputum serology● Lactic acid and blood pH● Haemoglobin and iron● Serum urea● Creatine phosphokinase and lactate

dehydrogenase● Electrolytes

Page 30: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Tests = blood, blood and more blood...

Many tests require a blood sample

Page 31: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood glucoseBlood cholesterols and triglycerides

Kidney functionC-reactive protein

Liver enzymes

AnaemiaLactic acidosis

Page 32: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood glucose

Normal range 4-8 millimoles per litre (µmol/L)

High glucose ?= kidney disease, neuropathy, insulin resistance, cardiovascular disease

Drugs: PIs, tenofovir, AZT?

Page 33: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

Low-density lipoproteins (LDLs) or "bad" cholesterol, and high-density lipoproteins (HDLs) or "good" cholesterol – ratio is key measure

Insulin resistance, metabolic syndrome, cardiovascular disease

Drugs: PIs, AZT, efavirenz

Page 34: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

Total cholesterol

Target level under 5.2 µmol/L (4-6.4 µmol/L)

Page 35: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

LDL cholesterol

Target level under 3.4 µmol/L

Page 36: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

HDL cholesterol

Target level over 0.9 µmol/L

Page 37: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

Cholesterol – CV risk cannot be judged on cholesterol levels alone, HDL:LDL ratio, lifestyle, BMI, age and other factors are important

Smoking!

Page 38: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood cholesterols and triglycerides

Triglycerides

Fasted levels <2.2 µmol/L normal, 2.2–4.4 µmol/l borderline, >11 µmol/L very high

Each +1.1 µmol/L increased the risk of a heart attack by about 25% in men and 60% in women

Page 39: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Urine

Dipstick test

●Protein – kidney (tenofovir) << mostly albumin●Glucose – insulin resistance (PIs), kidney (tenofovir, indinavir?, atazanavir?)●Bilirubin – liver ( X atazanavir)

Sensitive but not specific

Page 40: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Kidney function

Urine dipstick test or blood test = first test and is indicative but inconclusive

Page 41: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Kidney function

●Serum creatinine (blood, not very specific or sensitive)●Creatinine clearance (blood and/or urine samples over 24 hours)●Calculated creatinine clearance (1 blood sample) – also called estimated glomular filtration rate (eGFR)

Creatinine clearance can increase in pregnancy

Page 42: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Kidney function

Different formulas to calculate GFRhttp://en.wikipedia.org/wiki/Glomerular_filtration_rate

Page 43: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

C-reactive protein

Risk of diabetes, hypertension and CV disease

Low risk: <1mg/LHigh risk: >3mg/L

Drugs: PIs?, AZT?

C-reactive protein is a plasma protein produced by the liver (so, another blood test...)

Page 44: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

C-reactive protein

C-reactive protein is also marker of inflammation from infection but seems to be a reliable marker for CV disease in HIV regardless of HAART

http://gateway.nlm.nih.gov/MeetingAbstracts/102261383.html

Page 45: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

AST, ALT, ALP, GGT and bilirubin

Many conditions, some specific indications, complicated by hepatitis B and C coinfection, pharmacological agents (all kinds) and food

Drugs: ritonavir, nevirapine, efavirenz, tipranavir, atazanavir, indinavir, d4T - most ARVS and many other drugs may affect the liver

Page 46: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

ALT (alanine aminotransferase)

Normal range 7-30 units/L W, 10-55 units/L M

May be more reliable sign of liver damage

Page 47: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

AST (aspartate aminotransferase)

Normal range 9-25 units/L W, 10-40 units/L M

Unreliable sign of liver damage

Pregnancy may decrease AST

Page 48: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

ALP (alkaline phosphatase)

Normal range 30-100 units/L W, 45-115 units/L M

Non-specific sign of liver damage

Atazanavir and indinavir can raise ALP

Page 49: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

GGT (gamma glutamyl transferase)

Normal range >50 units/L W, >65 units/L M

Can be specific sign of liver damage

Page 50: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Interpretation requires experience and the whole picture

●ALP+ GGT normal = bone disease?●ALP+ GGT+ = bile ducts? liver damage?●10 x ALT/AST = viral hepatitis? ARVs?

Page 51: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Bilirubin

Direct (unconjugated) 0-7 µmol/L Total 0-17 µmol/L

Bilirubin levels slightly higher in males than females, black Africans.

Drugs: atazanavir, indinavir

Page 52: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Bilirubin

Jaundice clinically detectable at levels above 40 µmol/l.

Exception: with atazanavir (or ritonavir) if bilirubin levels around 60-70 µmol/l

Page 53: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Bilirubin ++ jaundice

Other enzymes ++ may show no outward sign

Page 54: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Q: what is the most liver-damaging over-the-counter (OTC) medicine?

Page 55: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

Q: what is the most liver-damaging over-the-counter (OTC) medicine?

A: Paracetamol

Page 56: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver enzymes

WHO's top 10 liver-damaging medicines

Paracetamol, troglitazone, valproic acid, d4T, halothene, 3TC, ddI, amiodarone, nevirapine, cotrimoxazole

The ABCs of liver disease, Edwin J Bernard, NAMhttp://www.aidsmap.com/files/file1000630.pdf

Page 57: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection Liver

PT time – Prothrombin Time

Also called INR - International Normalized Ratio

Evaluate the ability of blood to clot properly

Not an enzyme test

Page 58: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver

PT time – Prothrombin Time

Monitor anti-coagulants?, bleeding disorders, before surgery

Normal range 11-13.5 seconds1.5-2 times normal = too slow but no consensus on calibration of test as marker of over-fast clotting

Page 59: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Liver

PT time – Prothrombin Time

INR = (Pt test / PT normal) ISI

ISI = International Sensitivity Index for tissue factor (1-1.4)

Page 60: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Anaemia

Iron, B12, B6, folic acid, red blood count, heamoglobin (HGB), mean corpuscular haemoglobin (MCH), heamocrit (HCT), mean corpuscular volume (MCV)

Drugs: AZT (pregnant?)

Page 61: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Anaemia

Haemocrit

Normal ranges 40-52% M 35-35% W

Low haematocrit = anaemia?

Page 62: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Anaemia

Haemoglobin

Normal ranges 11.5- to 16.5g W 13-18g M per 100mL blood

Low haemoglobin = anaemia?

Page 63: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Anaemia

Mean corpuscular volume

Larger = anaemic, B6, B12, folic acid deficiency?

Smaller = anaemic, iron deficiency?

AZT (and smoking) can increase MCV without causing anaemia

Page 64: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Anaemia

Red blood count (total erythrocytes)

Normal range 3.8-5 W 4.5-6.5 M billion per litre or million per cubic millimitre of blood (1012/L).

Low count = anaemia? but not sensitive or specific = probably a first test

Page 65: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

The rest...

Blood chemistryhttp://www.aidsmeds.com/articles/CSTest_4730.shtml

http://www.aidsmeds.com/articles/CBCTest_4729.shtml

A-Z testshttp://www.aidsmap.com/cms1031936.asp

http://www.labtestsonline.org.uk/

Hepatitis C coinfection – liver and diagnosishttp://www.i-base.info/guides/hepc/livertests.html

http://www.i-base.info/guides/hepc/hcvtesting.html

Page 66: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Tests to avoid during pregnancy

● Amniocentesis● Chorionic villus sampling● Fetal scalp sampling● Cordocentis● Percutaneous umbilical cord sampling● Internal fetal labour monitoring (external ultrasound and fetal monitoring OK)

Page 67: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Plebotomy (having blood taken)

A cruel and unusual punishment - or nice chat with the nurse?

Page 68: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood count reference ranges

●Red blood count (RBC) 3.8 to 5 W 4.5-6.5 M million per mm3

●White blood count (WBC) 4-11 per mm3

●Haemoglobin (HGB, Hg) 11.5-16.5 W 13-18 M g per 100mL ●Neutropils 2-7.5 per mm3

●Lymphocytes 1.3-4 per mm3

●Platelets 150-440 per per mm3

●Mean corpuscular volume (MCV) 80-97

Page 69: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Blood count reference ranges

CD4 400-1,600 per mm3

CD4% 32-68%CD8 140-1000 per mm3

CD4:CD8 ratio 0.9-6

Page 70: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Sampling

Biggest causes of odd results are ‘sampling error’, ‘processing error’ or ‘sample

contamination’

wrong tube, wrong person's sample, cross-contamination, sample too hot/cold/old,

wrong reagent, wrongly set up equipment, not reading instructions, misreading output...

Page 71: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Results

One result is rarely conclusive

ANY unusual or unexpected results should ALWAYS be retested before making a

treatment decision

“Normal” is a difficult word – tests refer to reference ranges, can mean doctor/nurse is

happy with results even though high/low

Page 72: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Sensitive v specific

Sensitivity = reacts positively

Specificity = reacts positively in right circumstances

Page 73: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Sensitive v specific

Sensitivity = rule in Sensitivity refers to the proportion of people with disease who have a positive test result

Specificity = rule outSpecificity refers to the proportion of people without disease who have a negative test result.

Page 74: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Sensitive v specific

SnNout: when a sign, test or symptom has a high Sensitivity, a Negative result rules out the diagnosis.

SpPin: when a sign, test or symptom has a high Specificity, a Positive result

rules in the diagnosis.

Page 75: Tests and monitoring in HIV infection

Tests and monitoring in HIV infection

Sensitive v specific

Many “rapid” tests are highly sensitive but not specific enough to be definitive – prone to sample contamination

●Urine dipstick tests●Fingerprick tests